https://pharmadog.xyz/news/379367 pharmadog en 2026-09-08T10:00:00.000Z Roivant's inhaled drug mosliciguat achieves positive Phase 2 results in interstitial lung disease https://pharmadog.xyz/news/379431 pharmadog en 2026-09-08T10:00:00.000Z Roivant's experimental pulmonary hypertension drug meets Phase 2 goals https://pharmadog.xyz/news/379151 pharmadog en 2026-09-08T08:30:35.000Z Beam Therapeutics reports one-year data from early-stage AATD gene therapy trial https://pharmadog.xyz/news/379200 pharmadog en 2026-09-08T08:30:00.000Z Rural hospitals seek partnership deals as Trump Medicaid cuts threaten financial stability https://pharmadog.xyz/news/379195 pharmadog en 2026-09-08T08:30:00.000Z Reynolds launches fruit-flavored Vuse Pro vapes in Ohio despite lacking FDA authorization https://pharmadog.xyz/news/379199 pharmadog en 2026-09-08T08:30:00.000Z Medical student speaks out against weight bias in clinical training https://pharmadog.xyz/news/379198 pharmadog en 2026-09-08T08:30:00.000Z Experts say gloves are unnecessary for flu shots, urging a shift to reduce waste https://pharmadog.xyz/news/379197 pharmadog en 2026-09-08T08:30:00.000Z UnitedHealth executives donate over $100,000 to Rep. Katherine Clark ahead of midterms https://pharmadog.xyz/news/379196 pharmadog en 2026-09-08T08:30:00.000Z FDA approves Revolution Medicines’ pancreatic cancer drug Rasonque, but patients face delayed access https://pharmadog.xyz/news/379152 pharmadog en 2026-09-08T08:24:44.000Z Novartis shares tumble after late-stage failure of Avidity-acquired drug https://pharmadog.xyz/news/379047 pharmadog en 2026-09-08T07:28:55.000Z Novartis' DM1 drug del-desiran misses primary endpoint in Phase 3 HARBOR trial https://pharmadog.xyz/news/378899 pharmadog en 2026-09-08T07:00:00.000Z Benelux’s strong science base eyed for biotech scaling despite funding gaps https://pharmadog.xyz/news/378515 pharmadog en 2026-09-08T04:58:00.000Z AI can transform drug discovery only when its strengths are properly leveraged https://pharmadog.xyz/news/378516 pharmadog en 2026-09-08T04:20:00.000Z Four CDMOs to watch as biopharma outsourcing grows https://pharmadog.xyz/news/378387 pharmadog en 2026-09-08T04:09:00.000Z Moderna and Merck’s personalized mRNA cancer vaccine success spurs industry shift to faster, smaller-scale production https://pharmadog.xyz/news/378388 pharmadog en 2026-09-08T04:03:00.000Z Parkinson's drug pipeline diversifies as firms seek disease-modifying therapies https://pharmadog.xyz/news/379126 pharmadog en 2026-09-08T03:35:00.000Z Novartis' del-desiran fails primary endpoint in phase 3 Harbor trial for myotonic dystrophy type 1 https://pharmadog.xyz/news/134233 pharmadog en 2026-09-07T23:04:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/376639 pharmadog en 2026-09-07T17:17:43.000Z FDA grants accelerated approval to AstraZeneca's oral SERD for breast cancer despite advisory panel opposition https://pharmadog.xyz/news/376147 pharmadog en 2026-09-07T14:48:28.000Z Novartis reports Phase 3 pelacarsen trial fails to improve cardiovascular outcomes https://pharmadog.xyz/news/375639 pharmadog en 2026-09-07T11:13:52.000Z Novo Nordisk halts two cardiovascular trials of inflammation-targeting drug ziltivekimab https://pharmadog.xyz/news/375954 pharmadog en 2026-09-07T08:40:00.000Z Novo Nordisk abandons two phase 3 trials of ziltivekimab, dimming blockbuster hopes https://pharmadog.xyz/news/375043 pharmadog en 2026-09-07T07:53:43.000Z Novo Nordisk halts two late-stage ziltivekimab heart trials after futility finding https://pharmadog.xyz/news/374659 pharmadog en 2026-09-07T05:00:06.000Z Claret Capital Partners raises €575 million Fund IV to boost European biotech lending https://pharmadog.xyz/news/373659 pharmadog en 2026-09-06T23:07:31.000Z ADA panel still reviewing expulsions from June conference, further actions possible https://pharmadog.xyz/news/374910 pharmadog en 2026-09-06T14:27:00.000Z ADARx, backed by AbbVie, files for IPO to fund clinical-stage siRNA programs